Optimization of submerged culture conditions for the production of angiotensin converting enzyme inhibitor from Flammulina velutipes

Journal of Industrial Microbiology and Biotechnology

Volumn 29, Issue 5, 2002, Pages 292-295

  Kim, J M ^a   Ra, K S ^b   Noh, D O ^c   Suh, H J ^a  

^a Korea University   (South Korea)

^b Taegu Technical College   (South Korea)

^c Kaya University   (South Korea)

Author keywords

ACE inhibitor; Flammulina velutipes; Optimization; Submerged fermentation

Indexed keywords

AMMONIUM ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMIC ACID; MAGNESIUM SULFATE; POTASSIUM DIHYDROGEN PHOSPHATE; SUCROSE;

ARTICLE; BASIDIOMYCETES; CONTROLLED STUDY; DRUG SYNTHESIS; FLAMMULINA VELUTIPES; FUNGAL METABOLISM; FUNGUS CULTURE; LENTINUS EDODES; NONHUMAN;

AGARICALES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CULTURE MEDIA; HYDROGEN-ION CONCENTRATION; TEMPERATURE;

BASIDIOMYCOTA; FLAMMULINA; FLAMMULINA VELUTIPES; FUNGI; LENTINULA EDODES; LENTINUS;

EID: 0036851368     PISSN: 13675435     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jim.7000306     Document Type: Article

References (23)

1. Ahn JH. 1992. Studies on the Mycelial Growth and the Mass Production of Sporophores in Flammulina Velutiopes. MS Thesis, Korea Univ., Seoul, Korea.
2. Atkinson AB and JIS Robertson. 1979. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 2: 836-839.
3. Breene WM. 1990. Nutritional and medicinal value of specialty mushrooms. J Food Prot 53: 883-894.
4. Bu'Lock JD, D Hamilton, MA Hulme, AJ Powell, D Shepherd, HM Smalley and GN Smith. 1965. Metabolic development and secondary biosynthesis in Penicillium urticae. Can J Microbiol 11: 765-778.
5. Chiu KW, AHW Lam and PKT Pang. 1995. Cardiovascular active substances from the straw mushroom, Volvariella volvacea. Phytother Res 9: 93-99.
6. Choi HS, HY Cho, HC Yang, KS Ra and HJ Suh. 2001. Angiotensin I converting enzyme inhibitor from Grifola frondosa. Food Res Int 34: 177-182.
7. Cushman DW and HS Cheung. 1971. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20: 1637-1648.
8. Garraway MO and RC Evans. 1991. Nutrition as a basis for the study of fungi. In: Garraway MO (Ed), Fungal Nutrition and Physiology. John Wiley and Sons, New York, pp. 71-221.
9. Gavras H. 1990. Angiotensin converting enzyme inhibition and its impact on cardiovascular disease. Circulation 81: 381-388.
10. Gruen HE and SH Wu. 1972. Promotion of stipe elongation in isolated Flammulina velutipes fruit bodies by carbohydrates, natural extracts and amino acid. Can J Bot 50: 803-818.
11. Hirai Y, M Ikeda, T Murayama and T Ohata. 1998. New monoterpentriols from fruiting body of Flammulina velutipes. Biosci Biotechnol Biochem 62: 1364-1368.
12. Hong JS and S Yoon. 1981. Fruit-body formation of Flammulina velutipes on the synthetic medium. Kor J Food Sci Technol 13: 233-240.
13. Kameda K, T Takaku, H Okuda and Y Kimura. 1987. Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin converting enzyme activity. J Nat Prod 50: 680-683.
14. Kohama Y, S Matsumoto, H Oka, T Teramoto, M Okabe and T Mimura. 1988. Isolation of an ACE-inhibitor from tuna muscle. Biochem Biophys Res Commun 156: 332-337.
15. Moon SH, SC Ha, DS Lee, JG Kim and SD Hong. 1995. Identification and culture condition of an Actinomycetes strain producing an angiotensin converting enzyme inhibitor. Kor J Appl Microbiol Biotechnol 23: 439-445.
16. Pateman JA and JR Kinghorn. 1976. Nitrogen metabolism. In: Smith JE and DR Berry (Eds), The Filamentous Fungi, Vol. 2. John Wiley and Sons, New York, pp. 159-237.
17. Song CH, CH Lee, JH Ahn, BS Hong and HC Yang. 1995. Standardization of chemically defined medium for the production of mycelium and basidiocarps in Flammulina velutiopes. Kor J Mycol 23: 53-60.
18. Suh HJ, JH Whang and H Lee. 1999. Angiotensin I converting enzyme inhibitory peptide from corn gluten hydrolysate. Biotechnol Lett 21: 1055-1058.
19. Tam SC, KP Yip, KP Fung and ST Chang. 1986. Hypotensive and renal effects of an extract of the edible mushroom Pleurotus sajor-caju. Life Sci 38: 1155-1161.
20. Wang H, TB Ng and VEC Ooi. 1998. Lectins from mushrooms. Mycol Res 102: 897-906.
21. Wasser SP and AL Weis. 1999. Therapeutic effect of substances occurring in higher basidiomycetes mushrooms: A modern perspective. Crit Rev Immunol 19: 65-96.
22. Yamamoto N. 1997. Antihypertensive peptides derived from food proteins. Biopolymers 43: 129-134.
23. Yaoita Y, K Amemiya, H Ohnuma, K Furumura, A Masaki, T Matsuki and M Kikuchi. 1998. Sterol constituents from edible mushrooms. Chem Pharm Bull 46: 944-950.